drugset / Trial / NCT05715437

Adductor Canal Block in Total Knee Arthroplasty

NCT05715437 ↗

Phase 4 Unknown 60 enrolled Assiut University
RandomizedFactorialTriple-blindOther

Summary

The purpose of this study is to evaluate whether adding ketamine to bupivacaine is superior to bupivacaine alone in terms of providing better pain control for 48 hours postoperatively after TKA.

Timeline

Start
2023-03
Primary completion
2024-03
Completion
2024-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 50 mg —
Background Bupivacaine Other / unclassified 0.5 % —
Background Bupivacaine Other / unclassified 20 ml —

Indications

No indication recorded.